首页> 外文期刊>Institutional investor >Prescription for Growth
【24h】

Prescription for Growth

机译:成长处方

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

He global economy is in the dumps, and no one knows when the bears will leave Wall Street. But some things are still pretty safe bets: Aging baby boomers will keep demanding more health care, and companies will look for more ways to control the growth of medical costs-or betteryet, reduce them outright. All of which is good news for Medco Health Solutions, the largest U.S. administrator of pharmacy benefits by revenue. The Franklin Lakes, New Jersey-based company posted a very nonrecessionary 20.9 percent jump in net income last year, to $1.1 billion, on revenues that were up 15.3 percent, to $51.3 billion. Record mail-order-prescription revenue boosted results. A 15 percent increase in the price of prescription drugs also helped. Management expects profits to grow an additional 15 percent in 2009, notwithstanding the sharp decline in therneconomy. Medco has added $15 billion in new revenue in the past two years, according to CEO David Snow Jr.
机译:他的全球经济陷入困境,没人知道熊何时会离开华尔街。但是,有些事情仍然是相当安全的选择:婴儿潮时代的婴儿潮一代将继续要求更多的医疗保健,而公司将寻求更多的方法来控制医疗费用的增长,或者更好地控制医疗费用的增长。对于美国收入最大的药房收益管理者Medco Health Solutions而言,所有这些都是好消息。这家总部位于新泽西州富兰克林湖的公司去年的净收入增长了20.9%,至11亿美元,增幅非常大,无增幅,收入增长了15.3%,至513亿美元。创纪录的邮购处方收入提高了业绩。处方药价格上涨了15%也有所帮助。管理层预计,尽管经济效益急剧下降,2009年的利润仍将增长15%。首席执行官戴维·斯诺(David Snow Jr)表示,在过去两年中,Medco的新增收入增加了150亿美元。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号